AREV Life Sciences Global Corp.

AREVF · OTC
Analyze with AI
9/30/2023
6/30/2023
3/31/2023
12/31/2022
Operating Activities
Net Income-$29-$121-$169$80
Dep. & Amort.$14$14$14$29
Deferred Tax$0$0$0$15
Stock-Based Comp.$0$0$77-$247
Change in WC$9-$10$52$118
Other Non-Cash$1$1$1$1
Operating Cash Flow-$6-$116-$25-$6
Investing Activities
PP&E Inv.$0$0$0-$1
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0-$14
Investing Cash Flow$0$0$0-$1
Financing Activities
Debt Repay.$0$84$33-$9
Stock Issued$0$0$32$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$32$1
Financing Cash Flow$0$84$64-$8
Forex Effect$0-$0-$0-$0
Net Chg. in Cash-$6-$32$39-$15
Supplemental Information
Beg. Cash$7$39$0$15
End Cash$2$7$39$0
Free Cash Flow-$6-$116-$25-$7
AREV Life Sciences Global Corp. (AREVF) Financial Statements & Key Stats | AlphaPilot